Compile Data Set for Download or QSAR
Report error Found 40 Enz. Inhib. hit(s) with all data for entry = 758
TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289746(US10093671, Example 15)
Affinity DataIC50: 2nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289745(US10093671, Example 14)
Affinity DataIC50: 2nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289767(US10093671, Example 36)
Affinity DataIC50: 3nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289756(US10093671, Example 25)
Affinity DataIC50: 3nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289758(US10093671, Example 27)
Affinity DataIC50: 3nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289734(US10093671, Example 3)
Affinity DataIC50: 3nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289757(US10093671, Example 26)
Affinity DataIC50: 4nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289762(US10093671, Example 31)
Affinity DataIC50: 4nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289743(US10093671, Example 12)
Affinity DataIC50: 5nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289750(US10093671, Example 19)
Affinity DataIC50: 5nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289752(US10093671, Example 21)
Affinity DataIC50: 6nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289744(US10093671, Example 13)
Affinity DataIC50: 6nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289738(US10093671, Example 7)
Affinity DataIC50: 9nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289747(US10093671, Example 16)
Affinity DataIC50: 9nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289759(US10093671, Example 28)
Affinity DataIC50: 10nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289755(US10093671, Example 24)
Affinity DataIC50: 10nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289733(US10093671, Example 2)
Affinity DataIC50: 10nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289741(US10093671, Example 10)
Affinity DataIC50: 10nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289748(US10093671, Example 17)
Affinity DataIC50: 18nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289754(US10093671, Example 23)
Affinity DataIC50: 18nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289753(US10093671, Example 22)
Affinity DataIC50: 21nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289766(US10093671, Example 35)
Affinity DataIC50: 22nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289765(US10093671, Example 34)
Affinity DataIC50: 24nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289746(US10093671, Example 15)
Affinity DataIC50: 32nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289739(US10093671, Example 8)
Affinity DataIC50: 32nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289738(US10093671, Example 7)
Affinity DataIC50: 32nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289764(US10093671, Example 33)
Affinity DataIC50: 35nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289751(US10093671, Example 20)
Affinity DataIC50: 37nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289760(US10093671, Example 29)
Affinity DataIC50: 64nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289732(US10093671, Example 1)
Affinity DataIC50: 64nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289740(US10093671, Example 9)
Affinity DataIC50: 83nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289739(US10093671, Example 8)
Affinity DataIC50: 94nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289749(US10093671, Example 18)
Affinity DataIC50: 97nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289763(US10093671, Example 32)
Affinity DataIC50: 110nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289742(US10093671, Example 11)
Affinity DataIC50: 170nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289761(US10093671, Example 30)
Affinity DataIC50: 320nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289736(US10093671, Example 5)
Affinity DataIC50: 800nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289735(US10093671, Example 4)
Affinity DataIC50: 1.16E+3nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289737(US10093671, Example 6)
Affinity DataIC50: 1.93E+3nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent

TargetLarge envelope protein(HBV-D)
Hoffmann-La Roche

US Patent
LigandPNGBDBM289768(US10093671, Example 37)
Affinity DataIC50: 4.42E+3nMT: 2°CAssay Description:HepG2.2.15 cells were seeded in duplicate into white, 96-well plates at 1.5×104 cells/well. The cells were treated with a three-fold serial dilution ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2019
Entry Details
Go to US Patent